A randomized, double-blind, placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome

Journal of Clinical Psychiatry

Volumn 61, Issue 9, 2000, Pages 643-648

  Hickie, I B ^a   Wilson, A J ^a   Wright, J M ^a   Bennett, B K ^a   Wakefield, D ^a   Lloyd, A R ^a  

^a ST GEORGE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; MOCLOBEMIDE; MONOAMINE OXIDASE A INHIBITOR; NEFAZODONE; PHENELZINE; PLACEBO;

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; ENERGY; FEMALE; HUMAN; IMMUNE RESPONSE; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; PHYSICAL DISABILITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033808227     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v61n0909     Document Type: Article

References (35)

1. The chronic fatigue syndrome: A comprehensive approach to its definition and study
2. Cognitive behaviour therapy for the chronic fatigue syndrome: A randomized controlled trial
3. Cognitive behaviour therapy for chronic fatigue syndrome: A randomized controlled trial
4. The treatment of chronic fatigue syndrome: Science and speculation
5. Fatigue syndromes: A comparison of chronic postviral fatigue with neuromuscular and affective disorders
6. The psychiatric status of patients with chronic fatigue syndrome
7. The relationship of chronic fatigue to psychiatric illness in community, primary care and tertiary care samples
8. The nature and extent of fatigue
9. Phenelzine versus imipramine in the treatment of probable atypical depression: Defining syndrome boundaries of selective MAOI responders
10. Treatment of atypical depression with cognitive therapy or phenelzine
11. Unique genetic and environmental determinants of prolonged fatigue: A twin study
12. Complex genetic and environmental relationships between psychological distress, fatigue and immune functioning: A twin study
13. The temporal stability and co-morbidity of prolonged fatigue: A longitudinal study in primary care
14. Fatigue and psychiatric disorder: Different or the same?
15. Reviving the diagnosis of neurasthenia
16. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome
17. A catecholamine model of fatigue
18. Nefazodone for patients with chronic fatigue syndrome
19. Randomized, double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome
20. An open study of the efficacy and adverse effects of moclobemide in patients with the chronic fatigue syndrome
21. What is myalgic encephalomyelitis?
22. The structured clinical interview for DSM-III-R (SCID), I: History, rationale, and description
23. The use of nitrogen mustards in the palliative treatment of carcinoma
24. Can the chronic fatigue syndrome be defined by distinct clinical features?
25. Chronic fatigue syndrome criteria: A critique of the requirement for multiple physical complaints
26. Immunological abnormalities in the chronic fatigue syndrome
27. Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression
28. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: A double-blind, placebo-controlled trial
29. Cognitive-behavioural therapy and the treatment of chronic fatigue syndrome
30. The assessment and management of chronic fatigue and chronic fatigue syndrome
31. A behavioural approach based on reconstructing the sleep-wake cycle
32. Cognitive deficits in patients suffering from chronic fatigue syndrome, acute infective illness or depression